Bioscience

IGC teams with University of Michigan to launch nonprofit spinoff

August 23, 2012

By Flinn Foundation

The International Genomics Consortium has launched a nonprofit spinoff company, Paradigm, in partnership with the University of Michigan. The firm will offer doctors and health care organizations to access whole gene and multi-gene sequencing and molecular diagnostics, and support clinical trials.

Paradigm will have offices in Phoenix and at the University of Michigan in Ann Arbor, and is expected to employ 15 people at each of its offices within the first three years. The firm is the sixth company launched by Robert Penny, CEO of IGC, including the Molecular Profiling Institute.

“Paradigm builds on our ever-increasing understanding of the interplay of multiple disease-causing genes and how this affects sensitivity to specific treatment regimens,” Dr. Penny said. “We will bring our expertise to bear to create true personalized medicine options for clinicians and their patients.”


For more information:

U Michigan Partnering with IGC to Create Sequencing-Based PGx Non-Profit,” GenomeWeb, 09/05/2012

Robert Penny, founder of IGC, to launch sixth company,” Phoenix Business Journal, 08/16/2012

Valley non-profit, University of Michigan team up for genetic analysis,” Arizona Republic, 08/16/2012

ICG news release, 08/16/2012